Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
TransDigm Group
TDG
$69B
| $35.8M | 0.01% |
66,663
-48,356
| -42% | -$28.5M |
|
1252
PUT
W.W. Grainger
GWW
$62.1B
| $35.7M | 0.01% |
78,500
-18,000
| -19% | -$8.75M |
|
1253
Design Therapeutics
DSGN
$898M
| $35.6M | 0.01% |
2,545,658
+10,956
| +0.4% | +$148K |
|
|
LSXMA
1254
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $35.6M | 0.01% |
1,344,405
-868,706
| -39% | -$26M |
|
1255
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $35.6M | 0.01% |
+1,207,918
| New | +$35.7M |
|
1256
CALL
Unilever
UL
$134B
| $35.5M | 0.01% |
688,800
+123,733
| +22% | +$6.3M |
|
1257
Novavax
NVAX
$1.34B
| $35.4M | 0.01% |
689,159
+124,043
| +22% | +$6.43M |
|
1258
FIGS
FIGS
$2.43B
| $35.4M | 0.01% |
3,886,244
+3,712,899
| +2,142% | +$47.4M |
|
1259
AB InBev
BUD
$156B
| $35.4M | 0.01% |
655,485
+629,318
| +2,405% | +$35.3M |
|
1260
Cogent Communications
CCOI
$532M
| $35.3M | 0.01% |
+580,788
| New | +$35.7M |
|
|
DNB
1261
DELISTED
Dun & Bradstreet
DNB
| $35.3M | 0.01% |
2,345,884
+1,747,575
| +292% | +$28.2M |
|
|
EOCW
1262
DELISTED
Elliott Opportunity II Corp.
EOCW
| $35.3M | 0.01% |
3,627,217
-173,049
| -5% | -$1.69M |
|
1263
CALL
Direxion Daily Energy Bull 2X ETF
ERX
$251M
| $35.2M | 0.01% |
750,800
+391,000
| +109% | +$23.5M |
|
1264
Yum China
YUMC
$16.3B
| $35.2M | 0.01% |
726,269
+603,578
| +492% | +$25.4M |
|
1265
Arrow Electronics
ARW
$10.8B
| $35.2M | 0.01% |
314,086
+214,488
| +215% | +$25M |
|
1266
Goodyear
GT
$1.78B
| $35.2M | 0.01% |
3,282,070
+673,377
| +26% | +$8.43M |
|
1267
Lumen
LUMN
$6.75B
| $35.1M | 0.01% |
3,216,995
+1,938,421
| +152% | +$21.8M |
|
1268
PENN Entertainment
PENN
$2.55B
| $35M | 0.01% |
1,151,110
+540,383
| +88% | +$18.2M |
|
1269
Popular Inc
BPOP
$11.4B
| $35M | 0.01% |
454,851
-337,840
| -43% | -$26.9M |
|
|
1270
PNC Financial Services
PNC
$102B
| $35M | 0.01% |
221,611
-2,344,701
| -91% | -$393M |
|
1271
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $34.9M | 0.01% |
1,022,000
+519,700
| +103% | +$16.2M |
|
1272
CALL
Intercontinental Exchange
ICE
$86.4B
| $34.9M | 0.01% |
371,200
-47,200
| -11% | -$5.05M |
|
1273
PUT
Colgate-Palmolive
CL
$73.4B
| $34.9M | 0.01% |
435,200
-44,400
| -9% | -$3.47M |
|
|
AVDX
1274
DELISTED
AvidXchange
AVDX
| $34.8M | 0.01% |
5,672,184
+2,346,372
| +71% | +$18.6M |
|
1275
Exelixis
EXEL
$12.6B
| $34.8M | 0.01% |
1,672,412
+1,607,162
| +2,463% | +$33.1M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.